Predictor of Early Remission of Diabetic Macular Edema under As-Needed Intravitreal Ranibizumab

The early remission of diabetic macular edema (DME) often occurs in eyes treated with anti-vascular endothelial growth factor (VEGF) treatment. We retrospectively reviewed and characterized eyes with early remission of DME at six months in 80 eyes under pro re nata (PRN) intravitreal ranibizumab (IV...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Sci Rep
Asıl Yazarlar: Yoshitake, Tatsuya, Murakami, Tomoaki, Suzuma, Kiyoshi, Fujimoto, Masahiro, Dodo, Yoko, Tsujikawa, Akitaka
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Nature Publishing Group UK 2019
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6527559/
https://ncbi.nlm.nih.gov/pubmed/31110273
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-019-44078-6
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller